In a first-in-human phase 1 trial in 41 patients with recurrent glioblastoma, an oncolytic virus treatment designed by Brigham researchers extended survival, especially among those…
Glioblastoma, a notoriously hard-to-treat brain cancer, is known for causing cognitive decline as it infiltrates the brain’s neighboring networks. However, this aggressive encroachment could also…
An MIT research team has made a breakthrough in improving the effectiveness of engineered T cells, or chimeric antigen receptor (CAR) T cells, in treating…
A global collaboration directed by a researcher from Stanford Medicine has discovered over 50 genes associated with glioma, a rare brain cancer. While the majority…
A groundbreaking new study introduces a promising therapy for glioblastoma that combines oncolytic virus injections into tumors with intravenous immunotherapy. The treatment, which is safe…
A novel ultrasound technique utilizing microbubbles temporarily opens the blood-brain barrier to treat glioblastoma in humans. One of the biggest challenges in treating glioblastoma, a…
A novel hydrogel developed by Johns Hopkins University researchers cured 100% of mice with aggressive brain cancer by combining anticancer drugs and antibodies to target…
Glioblastoma (GBM) is the most common and deadliest type of brain cancer with a five-year survival rate of only 5%. Researchers at Penn State College…
Findings from a seven-year research project suggests that there could be a new approach to treating one of the most common and devasting forms of…
Results from pre-clinical research show iron-like compound holds promise for treating patients with glioblastoma, an aggressive brain cancer. A novel therapy studied at the Medical…
Researchers from MIT and the Whitehead Institute have discovered a vulnerability of brain cancer cells that could offer a new target for the treatment of…
A new study from scientists at Columbia University Medical Center pinpoints the genetic cause of glioblastoma and found that drugs that target the protein produced…
A new vaccine has been found to extend the life of patients suffering from recurrent glioblastoma multiforme. A phase 2 clinical trial showed that by…